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Samarium doped hydroxyapatite (Sm:HAp), Ca
10−𝑥
Sm
𝑥
(PO
4
)
6
(OH)
2
(HAp), bionanoparticles with different 𝑥Sm have been
successfully synthesized by coprecipitation method. Detailed characterization of samarium doped hydroxyapatite nanoparticles
(Sm:HAp-NPs) was carried out using X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron
microscopy (TEM), and Fourier transform infrared spectroscopy (FTIR).The biocompatibility of samarium doped hydroxyapatite
was assessed by cell viability.The antibacterial activity of the Sm:HAp-NPswas tested against Gram-negative bacteria (Pseudomonas
aeruginosa and Escherichia coli) and Gram-positive bacteria (Enterococcus faecalis and Staphylococcus aureus). A linear increase of
antimicrobial activity of P. aeruginosa has been observed when concentrations of Sm:HAp-NPs in the samples with 𝑥Sm = 0.02were
higher than 0.125mg/mL. For Sm:HAp-NPs with 𝑥Sm = 0.05 a significant increase of antibacterial activity on E. coli was observed
in the range 0.5–1mg/mL. For low concentrations of Sm:HAp-NPs (𝑥Sm = 0.05) from 0.031 to 0.125mg/mL a high antibacterial
activity on Enterococcus faecalis has been noticed. A growth of the inhibitory effect on S. aureuswas observed for all concentrations
of Sm:HAp-NPs with 𝑥Sm = 0.02.
1. Introduction
Nowadays, the development of new nanoscale materials has
reached such complexity that engineered particles have the
potential to be used for applications in various areas ranging
from medicine to environment and electronics. The most
studied engineered particles are the inorganic ones and
mostly the ones that exhibit biological properties [1–3].
Hydroxyapatite, b1
10
(`\
4
)
6
(OH)
2
(HAp), is a calcium
phosphate ceramic material and also the major inorganic
component in bones and teeth of animals and humans
[4]. Due to its excellent biocompatibility, bioactivity, and
osteoconductivity, HAp is widely investigated and promoted
in all biomaterial related research areas [5–8].
Apatites, especially HAp, have a strong affinity to ion
substitution and a real potential for being used as struc-
tural matrices for materials design. Due to the tendency of
substituting Ca2+ ions with other divalent elements, mostly
metals such as Ag+, Cu2+, and Zn2+, hydroxyapatite is widely
used to develop new compounds with exquisite properties.
In the last years, the attention has been focused on the
family of rare-earth elements as substituents of Ca2+ in
the HAp structure [9–12]. Hydroxyapatite doped with rare-
earth ions is of interest in the area of biomaterials for bone
related applications [13]. Lanthanides, also called rare-earth
elements, are the family of elements between lanthanum and
lutetium. These elements exhibit a pronounced biological
activity, and they are able to replace Ca2+ ions in structured
molecules [14–16]. One of the most important representative
elements from the lanthanides family is samarium. Sm3+ ions
are one of the most interesting ions to be analyzed due to
their use in high-density optical storage, exquisite optical
properties, and antibacterial properties [17, 18].
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Figure 1: Comparative representation of the experimental XRD
patterns of the Sm:HAp samples with 𝑥Sm = 0, 𝑥Sm = 0.02, and 𝑥Sm =
0.05 and the characteristic lines of hydroxyapatite according to the
ICDD-PDF number 9-432.
Recently [19], the primary tests concerning the adherence
of Enterococcus faecalis ATCC 29212 (Gram-positive bacteria)
to samariumdoped hydroxyapatite showed high antibacterial
activity against Enterococcus faecalis ATCC 29212. Here,
we have synthesized the samarium doped hydroxyapatite
bionanoparticles (Sm:HAp-NPs), with other concentrations
of samarium (𝑥Sm = 0, 𝑥Sm = 0.02, and 𝑥Sm = 0.05) by a
quick and cheap method of synthesis. The present paper
is mainly focused on the antibacterial activity of samarium
doped hydroxyapatite bionanoparticles (Sm:HAp-NPs). The
structural and morphological studies have confirmed the
formation of Sm:HAp-NPs with the characteristics of pure
apatite with good crystal structure. The particle sizes were
measured by transmission electron microscopy (TEM) and
using dynamic light scattering (DLS). The biocompatibility
of the Sm:HAp-NPs was evaluated using in vitro assays,
consisting in the quantification of hFOB 1.19 osteoblasts cells
viability. The antibacterial activity of Sm:HAp-NPs with 𝑥Sm
= 0, 𝑥Sm = 0.02, and 𝑥Sm = 0.05 was tested against Gram-
negative bacteria (Pseudomonas aeruginosa and Escherichia
coli) and Gram-positive bacteria (Enterococcus faecalis and
Staphylococcus aureus).
2. Materials and Methods
2.1. Materials. All the reagents used for the synthesis, ammo-
nium dihydrogen phosphate [(NH
4
)
2
HPO
4
], calcium nitrate
tetrahydrate [Ca(NO
3
)
2
⋅4H
2
O], Samarium(III) nitrate hex-
ahydrate [Sm(NO
3
)
3
⋅6H
2
O], and ammonia (NH
3
), were
purchased from Sigma-Aldrich and used without further
purification.
2.2. Synthesis of Samarium Doped Hydroxyapatite.
Nanocrystalline hydroxyapatite doped with Sm,
Ca
10−xSmx(PO4)6(OH)2, with 𝑥Sm = 0, 𝑥Sm = 0.02, and
𝑥Sm = 0.05, was obtained by setting the atomic ratio of
Sm/[Sm + Ca] from 0% to 5% and [Ca + Sm]/P as 1.67. The
Sm(NO
3
)
3
⋅6H
2
O and Ca(NO
3
)
2
⋅4H
2
O were dissolved in
300mLdeionisedwater.On the other hand, the (NH
4
)
2
HPO
4
was dissolved in 300mL deionised water. The [Ca + Sm]
solution was put into a Berzelius and stirred at 100∘C for
30 minutes. The (NH
4
)
2
HPO
4
solution was added drop by
drop into the [Ca + Sm] solution and stirred for 2 h. The pH
was adjusted to 10 with NH
3
and stirred continuously for
30 minutes. After the reaction, the deposited mixtures were
washed several times with deionised water. The resulting
material (Sm:HAp) was dried at 100∘C.
2.3. Characterisation. The X-ray diffraction measurements
for Sm:HAp samples were recorded using a Bruker D8
Advance diffractometer, with nickel filtered Cu K𝛼 (𝜆 =
1.5418 A˚) radiation, and a high efficiency one-dimensional
detector (Lynx Eye type) operated in integration mode. The
diffraction patternswere collected in the 2𝜃 range between 15∘
and 90∘, with a step of 0.02∘ and 34 s measuring time per step.
The particle size was measured by the SZ-100 Nanoparticle
Analyzer (Horiba) using dynamic light scattering (DLS).
The signal obtained from the scattered light is fed into a
multichannel correlator that generates a function used to
determine the translational diffusion coefficient of the par-
ticles analyzed. The Stokes-Einstein equation is then used to
calculate the particle size. The scanning electron microscopy
(SEM) study was performed on a HITACHI S2600N-type
microscope equipped with an energy dispersive X-ray attach-
ment (EDAX/2001 device). Energy dispersive X-ray analysis,
referred to as EDS or EDAX, was used to identify the
elemental composition of materials. The functional groups
present in samarium doped hydroxyapatite nanopowders
were identified by Fourier transform infrared spectroscopy,
FTIR, using a Spectrum BX spectrometer. The spectra were
recorded on 10mm diameter tablets containing 1% KBr and
99% samarium doped hydroxyapatite nanopowder in the
range of 500 to 4000 cm−1 with a resolution of 4 cm−1.
2.4. Cell Cultures and Conditions. The hFOB 1.19 osteoblasts
cells lines were purchased from American Type Culture Col-
lection (ATCC CCL-12, Rockville, MD, USA). The cells were
routinely maintained in Dulbecco’s modified Eagle’s medium
(Sigma-Aldrich) supplemented with 10% fetal bovine serum
(Sigma-Aldrich) and 1% antibiotic antimycotic solution
(including 10,000 units penicillin, 10mg streptomycin, and
25 𝜇g amphotericin B per mL, Sigma-Aldrich) at 37∘C in a
humidified atmosphere of 5% CO
2
. The cultured cells were
loaded on samarium doped hydroxyapatite discs at a seeding
density of 5 × 104 cells/cm2 in 24-well plates. Cells cultured
in 24-well plates at the same seeding density were used as
control.
2.5. In Vitro Cytotoxicity Assay. Biocompatibility test of the
samarium doped hydroxyapatite (𝑥Sm = 0, 𝑥Sm = 0.02, and
𝑥Sm = 0.05) discs has been made using primary osteoblast
cell line. After osteoblast culture achievement, the cells were
treatedwith trypsin 0.05% and spitted in 35/35mmPetri dish.
Journal of Nanomaterials 3
(a) (b)
(c) (d)
Figure 2: The TEM images at low resolution of Sm:HAp with 𝑥Sm = 0 (a), 𝑥Sm = 0.02 (b), and 𝑥Sm = 0.05 (c). The SAED analysis of Sm:HAp
with 𝑥Sm = 0.02 (d).
Cells were seeded at a density of 105 cells/mL in a Petri dish
and incubated with samarium doped hydroxyapatite (𝑥Sm =
0, 𝑥Sm = 0.02, and 𝑥Sm = 0.05) for 4, 12, and 24 hours.The cell
viability was determined by MTT (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide) reduction test. The
cells were incubated (5% CO
2
atmosphere, T = 37∘C) for
4 h with MTT (0.1mg/mL). The optical density at 595 nm,
for each well, was then determined using a Tecan multiplate
reader (Tecan GENios, Gro¨dic, Germany). The absorbance
from thewells of cells cultured in the absence of ceramic discs
was used as the 100% viability value.
2.6. Antimicrobial Studies. The antibacterial activity of
Sm:HAp-NPs was assessed by the Kirby-Bauer disc diffu-
sion technique againstGram-negative bacteria (Pseudomonas
aeruginosa and Escherichia coli) and Gram-positive bacteria
(Enterococcus faecalis and Staphylococcus aureus). The 5mg
of the Sm:HAp-NPs (𝑥Sm = 0, 𝑥Sm = 0.02, and 𝑥Sm = 0.05)
was put in Sterile Whatman filter paper discs of 5mm
diameter. Finally, the sterileWhatman filter paper was placed
on nutrient agar plates inoculated with bacterial cultures
and incubated at 37∘C for 24 h. The zone of inhibition was
measured by using antibiotic zone scale (Hi media) [20].
The effect of Sm:HAp-NPs on different phases of bacterial
growth was evaluated by adding various concentration of
Sm:HAp-NPs with 𝑥Sm = 0, 𝑥Sm = 0.02, and 𝑥Sm = 0.05
(40mg/mL) to overnight culture of Gram-negative bacteria
(Pseudomonas aeruginosa and Escherichia coli) and Gram-
positive bacteria (Enterococcus faecalis and Staphylococcus
aureus) in a 500mL culture flask and kept in an incubator
shaker at 27∘C for 24 h. The absorbance of the bacterial
culture was measured at 620 nm at various concentrations (1,
0.5, 0.25, 0.125, 0.62, and 0.031mg/mL).
3. Results and Discussion
Hydroxyapatite doped with metal ions can play a key role
in the development of modern chemotherapy on humans
and animals. The hydroxyapatite doped with samarium ions
with the molar compositions Ca
10−xSm(PO4)6(OH)2, where
𝑥Sm = 0, 𝑥Sm = 0.02, and 𝑥Sm = 0.05, was synthesized by
coprecipitation method. The structure, composition, and the
qualitative analysis of chemical bonds of the samariumdoped
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Figure 3: DLS showing mean average size of samarium doped hydroxyapatite.
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Figure 4: EDAX spectrum of the Sm:HAp (𝑥Sm = 0.02) samples and
simultaneous distributions of individual elements based on selected
region of the sample.
hydroxyapatite nanoparticles are discussed. Furthermore, the
antimicrobial evaluation of Sm:HAp was performed, too.
The XRD patterns of Sm:HAp (𝑥Sm = 0, 𝑥Sm = 0.02,
and 𝑥Sm = 0.05) and the standard data for the hexagonal
hydroxyapatite are shown in Figure 1. For all values of 𝑥Sm
the diffraction peaks can be well indexed to the hexagonal
Ca
10
(PO
4
)
6
(OH)
2
in P6
3
m space group (ICDD-PDF number
9-432). In the XRD analysis of Sm:HAp, peaks for any new
phase or impurity were not observed.
In good agreement with previous studies on Sm:HAp [21–
24], the XRD of Sm:HAp (𝑥Sm = 0, 𝑥Sm = 0.02, and 𝑥Sm =
0.05) have also shown that samples with samarium doped
hydroxyapatite exhibit the characteristics of pure apatite with
good crystal structure.
The diffraction peak intensities of the Sm:HAp powders
in the XRD spectra were reduced and the peak shapes were
broadened when the Sm concentration increased. In good
agreement with previous studies [25], the broadened peaks
when Sm concentration increased in the Sm:HAp samples are
attributed to the decrease of particle size.
In agreement with previous studies proposed by Ravin-
dran et al. [24] and Shirkhanzadeh et al. [26], these results
demonstrate that the Sm3+ ions have successfully substituted
Journal of Nanomaterials 5
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Figure 5: Infrared spectra in transmission mode of the Sm:HAp samples synthesized with 𝑥Sm = 0, 𝑥Sm = 0.02, and 𝑥Sm = 0.05.
Ca2+ ions without affecting the crystal structure of the
hydroxyapatite.
TEM images of Sm:HAp (𝑥Sm = 0, 𝑥Sm = 0.02, and 𝑥Sm =
0.05) at low resolution are presented in Figure 2.The samples
of samarium doped hydroxyapatite have a similar shape and
maintain the morphology of pure HAp (𝑥Sm = 0). We can
see that the Sm:HAp nanoparticles were relatively uniform in
shape for all the concentrations of samarium. The size of the
Sm:HAp samples decreases when the samarium concentra-
tion increases. The synthesized Sm:HAp nanoparticles have
ellipsoidal shape with regular surface and smoother edges.
The selected area electron diffraction (SAED) pattern
recorded from an area containing a large number of nanopar-
ticles is presented in Figure 2(d). The rings can be indexed
as ((002)), ((210)), ((211)), ((310)), ((222)), ((213)), ((004)),
and ((304)) reflections of the hexagonal HAp. Because other
reflections are not observed we can conclude that the results
are in good agreement with the XRD results which indicated
that the nanoparticles have a good crystal structure.
In Figure 3 the mean average size of samarium doped
hydroxyapatite obtained by dynamic light scattering (DLS)
measurements is presented. We can see that the diameter of
the particles is similar to the TEM size. This result shows
that the Sm:HAp nanoparticles in suspension are unagglom-
erated. On the other hand, the Sm:HAp nanoparticles are
monodisperse in water.
The elemental composition of the Sm:HAp samples
was highlighted by energy dispersive X-ray (EDX) analysis
(Figure 4). The EDX spectrum of Ca
10−xSmx(PO4)6(OH)2
confirmed the presence of calcium (Ca), phosphorus (P),
oxygen (O), and samarium (Sm) in the samples with 𝑥Sm
= 0.02 and 𝑥Sm = 0.05. The EDX spectrum of Sm:HAp
sample with 𝑥Sm = 0.02 is shown in Figure 4. The EDX
Mapping of Sm:HAp with 𝑥Sm = 0.02 is also presented
in Figure 4. EDX Mapping (element distribution images)
provides in addition to the conventional SEM image a mean-
ingful picture of the element distribution at the surface of
Ca
10−xSmx(PO4)6(OH)2 samples. The uniform distributions
of calcium (Ca), phosphor (P), oxygen (O), and samarium
(Sm) in the samples have been confirmed.
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Figure 6: MTT assay in hFOB 1.19 osteoblast cells incubated on
Sm:HAp (𝑥Sm = 0, 𝑥Sm = 0.02, and 𝑥Sm = 0.05).
The FTIR spectra of Sm:HAp (with 𝑥Sm = 0, 𝑥Sm = 0.02,
and 𝑥Sm = 0.05) samples synthesized by adapted coprecip-
itation method at 100∘C are shown in Figure 5. The FTIR
spectra of Sm:HAp samples for 𝑥Sm = 0, 𝑥Sm = 0.02, and 𝑥Sm
= 0.05 of samarium concentration are shown. The spectra of
Sm:HAp samples with concentrations of samarium 𝑥Sm = 0,
𝑥Sm = 0.02, and 𝑥Sm = 0.05 exhibited all vibrational modes
corresponding to phosphate and hydroxyl groups present in
HAp [27, 28]. The peak at 473 cm−1 is attributed to double
degenerated bending mode of the O–P–O bond while the
peaks at 1030–1100 cm−1 are attributed to triply degenerate
asymmetric stretching mode of the P–O bond. On the other
hand, nondegenerated symmetric stretching mode of the P–
O bond is observed at 962 cm−1 [29]. The peaks at 563 cm−1
and 603 cm−1 are are characteristic to ]4 vibration of PO
4
.
The bands at 872 cm−1 are attributed to CO
3
2− ions and
indicate B-type substitution, where CO
3
2− substitutes the
phosphate positions in the hydroxyapatite lattice [30, 31].
According to Nelson and Featherstone [32] and Barralet et al.
[33] the B-type substitution is predominant in hydroxyapatite
synthesized from precipitation reactions.
According to Predoi et al. [5, 34, 35] the absorption
peak in the region of 1600–1700 cm−1 is characteristic to
O–H bending mode and it is evidence of the presence of
absorbed water in the synthesized samples. In recent studies
on samarium doped hydroxyapatite nanoparticles (Sm:HAp-
NPs), Han et al. [29] attributed the weak band in the region
3200–3600 cm−1 to the stretching vibration of structural OH
bond. When the concentration of samarium increases in the
samples, the hydroxyl vibration band in the region 3200–
3600 cm−1 decreases in intensity. According to Barralet et
al. [36] a decrease of the hydroxyl vibration peak intensity
in the region 3200–3600 cm−1 and PO
4
3− stretching mode
at 960 cm−1 indicates an increase in the crystallinity of the
particles. This decrease in crystallinity of the particles is
consistent with the XRD results discussed before.
MTT assay is an assay which measures changes in
colour for measuring cellular proliferation. It is used to
determine cytotoxicity of potential medicinal agents and
other toxic materials. The 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide is reduced to purple formazan
in the mitochondria of living cells. To dissolve the insoluble
purple formazan product into a coloured solution a solu-
bilization solution is added. The hFOB 1.19 osteoblasts cells
were permanently monitored to detect any possible influence
due to samarium doped hydroxyapatite (𝑥Sm = 0, 𝑥Sm = 0.02,
and 𝑥Sm = 0.05) that might alter the cell growth, viability, and
proliferation.
hFOB 1.19 osteoblast cells incubated with the samarium
doped hydroxyapatite (𝑥Sm = 0, 𝑥Sm = 0.02, and 𝑥Sm = 0.05)
for 4, 12, and 24 hours presented a growth inhibition and
the decrease of viability, relating to control (100%). After 4
hours of exposurewith Sm:HAp anddiminish in proliferation
of the osteoblast cells at 68.92% (Sm:HAp with 𝑥Sm = 0),
68.56% (Sm:HApwith𝑥Sm = 0.02), and 68.12% (Sm:HApwith
𝑥Sm = 0.05) a tendency of linear increase of viability and
proliferation after 12 and 24 hours was observed.The increase
of viability and proliferation of the osteoblast cells after 24
hours at around 100% relating to control was observed for all
the samples (Figure 6).
Studies on the antimicrobial properties of these nanopar-
ticles were also performed. The antimicrobial activity of
Sm:HAp-NPs against Gram-negative (Pseudomonas aerugi-
nosa and Escherichia coli) and Gram-positive (Enterococcus
faecalis and Staphylococcus aureus) bacteria was evaluated.
Gram-negative bacteria can cause infections of surgical
site or wound, bloodstream infections, pneumonia, and
even meningitis. The Gram-negative bacteria have a unique
structure of the outer membrane which gives them the
ability to find new ways to be drug-resistant. The most
common Gram-negative infections include those caused
by Pseudomonas aeruginosa, Escherichia coli, Acinetobacter,
and Klebsiella. According to Poole [37], one of the most
worrisome characteristics of P. aeruginosa is its low antibiotic
susceptibility. On the other hand, P. aeruginosa can easily
develop resistance to antibiotics by mutation in chromoso-
mally encoded genes. Escherichia coli is known for virulence
in urinal tract infections and neonatal meningitis. It is known
that it is one of the main causes of urinary tract infections
[38].
The results of qualitative antibacterial activity evaluation
of Sm:HAp-NPs (𝑥Sm = 0.02 and 𝑥Sm = 0.05) on Gram-
negative and Gram-positive bacteria are shown in Figures 7
and 8.
The antibacterial activity of Sm:HAp-NPs (𝑥Sm = 0.02 and
𝑥Sm = 0.05) was evaluated. For the Sm:HAp-NPs with 𝑥Sm = 0
no activity against the Pseudomonas aeruginosa, Escherichia
coli, Enterococcus faecalis, and Staphylococcus aureus was
observed. On the other hand, the interactions of Sm:HAp-
NPs (𝑥Sm = 0.02 and 𝑥Sm = 0.05) with Gram-negative and
Gram-positive tested bacteria were different. The different
interaction between our compounds and microbial strains
tested could be due to differences occurring in the microbial
wall structures. The qualitative antibacterial activity eval-
uation on Sm:HAp-NPs was revealed by a clear zone of
inhibition when the concentrations were 𝑥Sm = 0.02 and 𝑥Sm
Journal of Nanomaterials 7
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Figure 7:Qualitative antibacterial activity evaluation of Sm:HAp-NPs (𝑥Sm = 0.02 and𝑥Sm = 0.05) onPseudomonas aeruginosa andEscherichia
coli Gram-negative bacteria.
= 0.05. A significant antibacterial activity was observed on
Sm:HAp-NPs with 𝑥Sm = 0.02 for all of the bacteria used.
In Figure 9 the antibacterial activity of Sm:HAp-NPs
(𝑥Sm = 0, 𝑥Sm = 0.02, and 𝑥Sm = 0.05) on Gram-negative
bacteria (Pseudomonas aeruginosa and Escherichia coli) is
shown. We can see that the P. aeruginosa was inhibited
when concentrations of Sm:HAp-NPs in the samples with
𝑥Sm = 0.02 and 𝑥Sm = 0.05 were higher than 0.125mg/mL.
When concentrations of Sm:HAp-NPs in the samples with
𝑥Sm = 0.02 and 𝑥Sm = 0.05 were lower than 0.125mg/mL,
an increase in microbial activity for the sample with 𝑥Sm =
0.02 was observed, while for the samples with 𝑥Sm = 0.05 the
values obtained are comparable to the control sample (M+).
A linear increase of antimicrobial activity of P. aeruginosa has
been observed when concentrations of Sm:HAp-NPs in the
samples with 𝑥Sm = 0.02 were higher than 0.125mg/mL. A
linear increase in the antimicrobial activity is also observed
for concentrations of Sm:HAp-NPs with 𝑥Sm = 0.05 in the
range 0.25–0.5mg/mL. When the concentration of Sm:HAp-
NPs in the samples with 𝑥Sm = 0.05 is equal to 1, the
antibacterial effect is maximum, and we can say that the P.
aeruginosa was completely killed. For all the concentrations
of Sm:HAp-NPs in the samples with 𝑥Sm = 0 an increase in
microbial activity was observed compared with that of the
control (M+). The antibacterial activity of Sm:HAp-NPs (𝑥Sm
= 0, 𝑥Sm = 0.02, and 𝑥Sm = 0.05) on E. coli can be seen in
Figure 9(b). The antibacterial activity of Sm:HAp-NPs on
E. coli is observed for concentrations of Sm:HAp-NPs with
𝑥Sm = 0.05 in the range 0.031–1.0mg/mL. For this sample
(Sm:HAp-NPs with 𝑥Sm = 0.05) a significant increase of
antibacterial activity of E. coli was observed in the range 0.5–
1mg/mL. An increase in microbial activity compared with
that of the control (M+) was observed in the region of 0.031–
0.5mg/mL for concentration of Sm:HAp-NPswith𝑥Sm = 0.02
and𝑥Sm = 0. In the region 0.5–1mg/mL, themicrobial activity
remains constant compared with the microbial activity in the
region 0.031–0.5mg/mL for the concentration of Sm:HAp-
NPs with 𝑥Sm = 0, while, for concentration of Sm:HAp-NPs
with 𝑥Sm = 0.02, a significant decrease is observed.
The antibacterial activity of Sm:HAp-NPs (𝑥Sm = 0,
𝑥Sm = 0.02, and 𝑥Sm = 0.05) on Gram-positive bacteria
(Enterococcus faecalis and Staphylococcus aureus) is shown in
Figure 10. Gram-positive and Gram-negative bacteria have
similar internal structures while the external structure is very
different. The most common Gram-positive bacteria such as
Enterococcus, Staphylococcus, and Streptococcus are responsi-
ble for a large number of serious infections worldwide. Based
on the recent update from the National Healthcare Safety
Network (NHSN) for surveillance of antimicrobial-resistant
pathogens [39], S. aureus and Enterococcus faecalis are the
most frequently isolated organisms. On the other hand, S.
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Figure 8: Qualitative antibacterial activity evaluation of Sm:HAp-NPs (𝑥Sm = 0.02 and 𝑥Sm = 0.05) against Enterococcus faecalis and
Staphylococcus aureus Gram-positive bacteria.
aureus and Enterococcus faecalis are the most commonly
present organisms in hospitals in Europe [40].
Figure 10(a) displays the antibacterial performance
against Gram-positive, Enterococcus faecalis, bacteria
obtained for the Sm:HAp-NPs (𝑥Sm = 0, 𝑥Sm = 0.02, and
𝑥Sm = 0.05). The antimicrobial test showed that Sm:HAp-
NPs with 𝑥Sm = 0 caused an increase in the microbial
activity of Enterococcus faecalis compared to that of the
control (M+). Antibacterial activity of Sm:HAp-NPs
samples with 𝑥Sm = 0.02 increased with an increase of the
Sm:HAp-NPs concentration from 0.031 to 1mg/mL. The
Sm:HAp-NPs samples with 𝑥Sm = 0.05 showed a weak
antibacterial activity for high concentrations of Sm:HAp-
NPs from 0.125 to 1mg/mL. For low concentrations of
Sm:HAp-NPs (𝑥Sm = 0.05) from 0.031 to 0.125mg/mL a
high antibacterial activity of Enterococcus faecalis has been
noticed. In Figure 10(b) the antibacterial activity of Sm:HAp-
NPs at various concentrations from 0.031 to 1mg/mL on
Staphylococcus aureus is shown when 𝑥Sm = 0, 0.02, and 0.05.
When 𝑥Sm = 0 the microbial activity is higher compared to
that of the control (M+) for all tested concentrations. At low
concentrations from 0.031 to 0.125mg/mL, the antibacterial
activity of Sm:HAp-NPs (𝑥Sm = 0.05) is high, while, for
higher concentrations of 0.25mg/mL, the antibacterial
activity decreases reaching values close to that of the control
(M+). A growth of the inhibitory effect on S. aureus was
observed for all concentrations of Sm:HAp-NPs with 𝑥Sm
= 0.02. For the concentrations from 0.5 to 1mg/mL of
Sm:HAp-NPs (𝑥Sm = 0.02) a very good antibacterial activity
was noticed.
A growing proportion of Gram-negative and Gram-
positive organisms display reduced susceptibility to antibi-
otics in communities and hospitals [41, 42]. According to
Woodford and Livermore [43] the resistant bacteria have
a significant impact on overall healthcare utilization and
costs. As a result of the increased antibiotic resistance of the
various microorganisms like bacteria, molds, viruses, and so
forth, new antimicrobial agents that could be used to prevent
infections are made. For the first time, this study has exam-
ined the synthesis of samarium doped hydroxyapatite at low
temperature by coprecipitation method and its antibacterial
activity. It could be concluded that the Sm:HAp-NPs have
the antibacterial potential for treating wounds or even for
covering medical instruments.
4. Conclusions
Samarium doped hydroxyapatite nanoparticles were suc-
cessfully synthesized by coprecipitation method. hFOB 1.19
osteoblast cells incubated with the samarium doped hydrox-
yapatite (𝑥Sm = 0, 𝑥Sm = 0.02, and 𝑥Sm = 0.05) exhibit an
increase of viability and proliferation after 24 hours at around
100% relating to control for all the samples.
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Figure 9:The antibacterial activity of Sm:HAp-NPs (𝑥Sm = 0, 𝑥Sm =
0.02, and𝑥Sm = 0.05) onPseudomonas aeruginosa (a) andEscherichia
coli (b) after 24 h.
The Sm:HAp-NPs were tested for their antibacterial
activity. The Sm:HAp-NPs with 𝑥Sm = 0, 0.02, and 0.05 have
antimicrobial property against theGram-negative andGram-
positive bacteria depending on the concentration of samar-
ium. The bioproperties of Sm:HAp-NPs can be controlled by
varying the samarium in hydroxyapatite. The antibacterial
properties of Sm:HAp-NPs can lead to increasing their
applicability in medical or environmental area.
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